An anti-SARS-CoV-2 metabolite is reduced in diabetes
A glucose-like metabolite, which is reduced in the serum of diabetic patients, inhibits the entry of SARS-CoV-2 into key cellular targets. The work led by Cheng and colleagues provides a molecular explanation for the increased risk of severe COVID-19 in patients with diabetes.
619 - Veterinary science
Is part of
Vergara-Alert, Júlia, and Nuria Izquierdo-Useros. 2022. "An Anti-SARS-Cov-2 Metabolite Is Reduced In Diabetes". Nature Metabolism 4 (5): 501-502. doi:10.1038/s42255-022-00569-x.
This item appears in the following Collection(s)
- ARTICLES CIENTÍFICS 
Copyright © 2022, Springer Nature Limited